IIM
REGN icon

INTECH Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

INTECH Investment Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.9M Buy
22,260
+12,941
+139% +$8.81M 0.13% 129
2026
Q1 		$7.2M Buy
9,319
+2,314
+33% +$1.77M 0.07% 253
2025
Q4 		$5.41M Sell
7,005
-277
-4% -$188K 0.05% 343
2025
Q3 		$4.09M Sell
7,282
-613
-8% -$347K 0.04% 445
2025
Q2 		$4.14M Sell
7,895
-90
-1% -$50.2K 0.04% 404
2025
Q1 		$5.06M Sell
7,985
-6,356
-44% -$4.37M 0.05% 321
2024
Q4 		$10.2M Buy
14,341
+2,438
+20% +$2.05M 0.1% 166
2024
Q3 		$12.5M Sell
11,903
-3,240
-21% -$3.61M 0.14% 137
2024
Q2 		$15.9M Buy
15,143
+2,245
+17% +$2.18M 0.2% 91
2024
Q1 		$12.4M Sell
12,898
-5,695
-31% -$5.42M 0.17% 114
2023
Q4 		$16.3M Buy
18,593
+10,104
+119% +$8.32M 0.24% 97
2023
Q3 		$6.99M Buy
8,489
+2,582
+44% +$2.03M 0.1% 208
2023
Q2 		$4.24M Sell
5,907
-33,018
-85% -$25.5M 0.04% 295
2023
Q1 		$32M Sell
38,925
-11,751
-23% -$8.86M 0.26% 98
2022
Q4 		$36.6M Buy
50,676
+7,000
+16% +$5.17M 0.27% 102
2022
Q3 		$30.1M Sell
43,676
-4,700
-10% -$2.96M 0.23% 116
2022
Q2 		$28.6M Buy
+48,376
New +$31.4M 0.16% 160

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

INTECH Investment Management's REGN Position: Q2 2026 in Review

INTECH Investment Management increased its Regeneron Pharmaceuticals (REGN) stake by 139% in Q2 2026, buying an estimated $8.81M and bringing the position to 22,260 shares worth $13.9M. The position accounts for 0.13% of the portfolio, ranked #129.

INTECH Investment Management first reported a position in REGN in Q2 2022 and has held it in 17 quarters since. The position peaked at $36.6M in Q4 2022. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • INTECH Investment Management held 22,260 shares of Regeneron Pharmaceuticals worth $13.9M as of Q2 2026.
  • INTECH Investment Management bought 12,941 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $8.81M.
  • Regeneron Pharmaceuticals made up 0.13% of INTECH Investment Management's portfolio in Q2 2026, its #129 holding.
  • INTECH Investment Management first reported a position in Regeneron Pharmaceuticals in Q2 2022 and has held it in 17 quarters since.
  • INTECH Investment Management's Regeneron Pharmaceuticals position peaked at $36.6M in Q4 2022.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.